Efficacy and Safety of Ticagrelor in Comparison to Clopidogrel in Elderly Patients With ST‐Segment–Elevation Myocardial Infarctions

BACKGROUND: Current guidelines recommend the new‐generation P2Y12‐inhibitor ticagrelor for patients with acute ST‐segment–elevation myocardial infarctions (STEMIs). The aim of the present study was to assess efficacy and safety of ticagrelor for elderly patients with STEMI (≥75 years) in an all‐come...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Am Heart Assoc
Autors principals: Schmucker, Johannes, Fach, Andreas, Mata Marin, Luis Alberto, Retzlaff, Tina, Osteresch, Rico, Kollhorst, Bianca, Hambrecht, Rainer, Pohlabeln, Hermann, Wienbergen, Harm
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2019
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6818018/
https://ncbi.nlm.nih.gov/pubmed/31538856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.119.012530
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars